Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Shitara

Showing results (11-20 of 375) with videos related to

Pageof 38
Sort By:
The Lancet. Oncology|February 16, 2010
Histological subtype of gastric cancer in JapanKohei Shitara, Kei Muro
Cases Journal|January 12, 2010
Gastrointestinal bleeding after aortic surgery: a case reportKohei Shitara, Ryoichi Wada
Gastrointestinal Cancer Research : GCR|May 23, 2009
Chemoradiotherapy for treatment of esophageal cancer in Japan: current status and perspectivesKohei Shitara, Kei Muro
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 11, 2013
[II. Which is the better choice for second- line treatment?; BEV or anti-EGFR after BEV treatment in patients with unresectable wild type K-ras colon cancer]Shozo Osera, Kohei Shitara
Therapeutic Advances in Medical Oncology|July 2, 2019
Next-generation sequencing and biomarkers for gastric cancer: what is the future?Akihito Kawazoe, Kohei Shitara
Expert Opinion on Biological Therapy|July 28, 2020
Antibody-drug conjugates to treat gastric cancerShigehiro Koganemaru, Kohei Shitara
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 22, 2025
Cell-Based Therapies in GI Cancers: Current Landscape and Future DirectionsIzuma Nakayama, Kohei Shitara
Case Reports in Oncology|August 27, 2010
A Case of Advanced Gastric Cancer with Poor Performance Status Which Improved by ChemotherapyKohei Shitara, Daisuke Takahari
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 20, 2015
[Clinical research of targeting therapy for cancer stem cells]Kohei Shitara, Toshihiko Doi
Gastrointestinal Cancer Research : GCR|January 20, 2010
Was the unexpected result a response to reintroduction of effective chemotherapy?Kohei Shitara, Kei Muro
Pageof 38

Showing results (11-20 of 375) with videos related to

Sort By:
Pageof 38
The Lancet. Oncology|February 16, 2010
Histological subtype of gastric cancer in JapanKohei Shitara, Kei Muro
Cases Journal|January 12, 2010
Gastrointestinal bleeding after aortic surgery: a case reportKohei Shitara, Ryoichi Wada
Gastrointestinal Cancer Research : GCR|May 23, 2009
Chemoradiotherapy for treatment of esophageal cancer in Japan: current status and perspectivesKohei Shitara, Kei Muro
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 11, 2013
[II. Which is the better choice for second- line treatment?; BEV or anti-EGFR after BEV treatment in patients with unresectable wild type K-ras colon cancer]Shozo Osera, Kohei Shitara
Therapeutic Advances in Medical Oncology|July 2, 2019
Next-generation sequencing and biomarkers for gastric cancer: what is the future?Akihito Kawazoe, Kohei Shitara
Expert Opinion on Biological Therapy|July 28, 2020
Antibody-drug conjugates to treat gastric cancerShigehiro Koganemaru, Kohei Shitara
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 22, 2025
Cell-Based Therapies in GI Cancers: Current Landscape and Future DirectionsIzuma Nakayama, Kohei Shitara
Case Reports in Oncology|August 27, 2010
A Case of Advanced Gastric Cancer with Poor Performance Status Which Improved by ChemotherapyKohei Shitara, Daisuke Takahari
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 20, 2015
[Clinical research of targeting therapy for cancer stem cells]Kohei Shitara, Toshihiko Doi
Gastrointestinal Cancer Research : GCR|January 20, 2010
Was the unexpected result a response to reintroduction of effective chemotherapy?Kohei Shitara, Kei Muro
Pageof 38